DXCM vs KAI · P/E 63, rev $2.50B vs P/E 36, rev $594.4M
DexCom Inc (DXCM) versus Kadant Inc (KAI) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Kadant Inc (KAI) is a specialty industrial machinery company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported KAI revenue for 2026-07-04 was $594.4M. Net income was $58.0M. KAI currently screens at market cap $3.69B and trailing P/E 35.6.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. KAI currently screens at market cap $3.69B and trailing P/E 35.6.
Not investment advice. Open the DXCM and KAI stock pages for the full models.
Not investment advice.